HemoCath is redefining the standard of cardiac care
Embedded Files
About HemoCath
About HemoCath
HemoCath Medical Ltd. is an Irish–US MedTech and Digital Health company commercializing the HemoDynamix™ AI Platform — a much-needed breakthrough solution for the diagnosis, treatment and monitoring of acute heart failure (ADHF).
HemoDynamix™ AI interprets precise hemodynamic data from the HemoCath™ catheter to provide predictive clinical decision support — transforming HF management from reactive to proactive — improving clinical outcomes and accelerating hospital discharge.
Leadership Team
Leadership Team
Our leadership team brings over 150 years of combined experience in medicine, engineering, commercialization, and corporate finance — with a proven record of turning breakthrough innovations into market successes.
Chris Glover, MD
CMO
Chris Glover, MD
CMO
Interventional Cardiologist,
Dir. Cardiac Catheterization Laboratory at University of Ottawa Heart Institute, Professor of Medicine, FRCPC
Eric Caron
CEO, Co-founder
Eric Caron
CEO, Co-founder
Entrepreneur and Engineer, Medtech / High-tech markets, Product dev. engineering, IP, Team building, Fundraising, Marketing and Sales. MBA
Des Regan
CTO, Co-founder
Des Regan
CTO, Co-founder
Medtech Engineer/Entrepr.,
Dir. of Product Development at Nordson Medical, Phillips Medisize and Medtronic, 23 patents, 4 exits
Deepak Kotak, MD
CSO
Deepak Kotak, MD
CSO
AI / Healthtech Entrepreneur,
Medtech VC Investor, formerly
10 yrs Critical Care Physician, Sr. medical & business advisor
Robert Orr
CFO
Robert Orr
CFO
Medtech Entrepreneur,
15 yrs CEO of Life360 Innov., formerly 20 yrs consulting tax/M&A at PwC and Deloitte
Our Mission
Our Mission
Redefining the standard of cardiac care by delivering the predictive clinical decision support that clinicians need to precisely manage acute heart failure and save lives.
Contact Us
Contact Us
Locations:
Galway, Ireland
Austin, TX, USA
Page updated
Report abuse